Recurrent, metastatic disease represents the most frequent cause of death for patients with
thyroid cancer, and radioactive iodine (RAI) remains a mainstay of therapy for these patients …

Context Modern management of differentiated thyroid cancer requires individualized care
plans that tailor the intensity of therapy and follow-up to the estimated risks of recurrence …

Thyroid nodules are extremely common and can be detected by sensitive imaging in more
than 60% of the general population. They are often identified in patients without symptoms …

The programmed cell death-1/programmed cell death ligand-1 (PD-1/PD-L1) immune
checkpoint proteins hold promise as diagnostic, prognostic, and therapeutic targets for …

Background: Ferroptosis plays a critical role in suppressing cancer progression, and its
essential regulator is glutathione peroxidase 4 (GPX4). High GPX4 expression can inhibit …

Background: Indolent nature but a high incidence of differentiated thyroid cancer (DTC)
remains a challenge for optimizing patient care. Therefore, prognostic factors present …

Prunella vulgaris, a traditional Chinese medicine, has been used to treat various benign and
malignant tumours for centuries in China. In our previous studies, Prunella vulgaris extract …

Thyroid cancer is the most frequent endocrine malignancy, with more than 500,000 cases
per year worldwide. Differentiated thyroid cancers are the most common forms with best …

Thyroid cancer is the most prevalent endocrine malignancy in the United States with greater
than 53,000 new cases in 2020. There is a significant gender disparity in disease incidence …

Background Papillary thyroid cancer (PTC) is unique among cancers in that patient age is a
consideration in staging. One of the most important modifications in the 8th Edition of the …